Journal of the American Chemical Society
Communication
T. Science 2012, 338, 500. (d) Ye, B.; Cramer, N. Science 2012, 338, 504.
(e) Guimond, N.; Gorelsky, S. I.; Fagnou, K. J. Am. Chem. Soc. 2011,
133, 6449. (f) Rakshit, S.; Grohmann, C.; Besset, T.; Glorius, F. J. Am.
Chem. Soc. 2011, 133, 2350. (g) Zhen, W.-C.; Wang, F.; Zhao, M.; Du,
Z.-Y.; Li, X.-W. Angew. Chem., Int. Ed. 2012, 51, 11819. (h) Li, G.-F.;
Ding, Z.-W.; Xu, B. Org. Lett. 2012, 14, 5338. (i) Michida, S.; Hirano, K.;
Satoh, T.; Miura, M. J. Org. Chem. 2009, 74, 6295.
(5) Wang, H.; Glorius, F. Angew. Chem., Int. Ed. 2012, 51, 7318.
(6) (a) Lian, Y.; Bergman, R. B.; Lavis, L. D.; Ellman, J. A. J. Am. Chem.
Soc. 2013, 135, 7122. (b) Lian, Y.; Bergman, R. B.; Ellman, J. A. Chem.
Sci. 2012, 3, 3088. (c) Lian, Y.; Huber, T.; Hesp, K. D.; Bergman, R. G.;
Ellman, J. A. Angew. Chem., Int. Ed. 2013, 52, 629. (d) Shi, X.-Y.; Li, C.-J.
Adv. Synth. Catal. 2012, 354, 2933. (e) Sharma, S.; Park, E.; Park, J.; Kim,
I. S. Org. Lett. 2012, 14, 906.
(7) Du, Y.; Hyster, T. K.; Rovis, T. Chem. Commun. 2011, 47, 12074.
(8) Zhu, C.; Xie, W.; Falck, J. R. Chem.Eur. J. 2011, 17, 12591.
(9) (a) Hou, W.; Zhou, B.; Yang, Y.-X.; Feng, H.-J.; Li, Y.-C. Org. Lett.
2013, 15, 1814. (b) Hesp, K. D.; Bergman, R. B.; Ellman, J. A. J. Am.
Chem. Soc. 2011, 133, 11430.
(10) (a) Chan, W.-W.; Lo, S.-F.; Zhao, Z.; Yu, W.-Y. J. Am. Chem. Soc.
2012, 134, 13565. (b) Hyster, T. K.; Rul, K. E.; Rovis, T. J. Am. Chem.
Soc. 2013, 135, 5364.
When the reaction was repeated on a larger scale, chromatog-
raphy resulted in the isolation of 86% of the azobenzene starting
material 7 along with a 9% yield of product 8a and ∼1%
uncyclized diarylamine 13.
In summary, formal [3 + 3] annulations of aromatic azides
with imines to give acridines and with azobenzenes to give
phenazines have been developed. These transformations proceed
by Rh(III)-catalyzed ortho C−H amination followed by
intramolecular electrophilic aromatic substitution and aromati-
zation. A broad range of acridines and phenazines can be
generated with precise placement of diverse functionality,
including unsymmetrical disubstituted derivatives. Moreover,
through the use of catalytic benzylamine to generate the requisite
imine in situ, aromatic aldehydes can be used to rapidly and
directly access acridines lacking substitution at the 9-position.
ASSOCIATED CONTENT
* Supporting Information
Procedures and spectral data. This material is available free of
■
S
(11) (a) Kim, J. Y.; Park, S. H.; Ryu, J.; Cho, S. H.; Kim, S. H.; Chang, S.
J. Am. Chem. Soc. 2012, 134, 9110. (b) Ryu, J.; Shin, K.; Park, S. H.; Kim,
J. Y.; Chang, S. Angew. Chem., Int. Ed. 2012, 51, 9904. (c) Shi, J.-J.; Zhou,
B.; Yang, Y.-X.; Li, Y.-C. Org. Biomol. Chem. 2012, 10, 8953. (d) Yu, D.-
G.; Suri, M.; Glorius, F. J. Am. Chem. Soc. 2013, 135, 8802.
(12) Selected reviews of C−H amination/amidation: (a) Davies, H. M.
L.; Manning, J. R. Nature 2008, 451, 417. (b) Dick, A. R.; Sanford, M. S.
Tetrahedron 2006, 62, 2439. (c) Du Bois, J. Org. Process Res. Dev. 2011,
15, 758. (d) Collet, F.; Dodd, R. H.; Dauban, P. Chem. Commun. 2009,
5061. (e) Armstrong, A.; Collins, J. C. Angew. Chem., Int. Ed. 2010, 49,
2282.
(13) Ru-catalyzed aryl C−H amidations with sulfonyl azides:
(a) Yadav, M. R.; Rit, R. K.; Sahoo, A. K. Org. Lett. 2013, 15, 1638.
(b) Bhanuchandra, M.; Yadav, M. R.; Rit, R. K.; Kuram, M. R.; Sahoo, A.
K. Chem. Commun. 2013, 49, 5225. (c) Kim, J.; Kim, J.; Chang, S.
Chem.Eur. J. 2013, 19, 7328. (d) Zheng, Q.-Z.; Liang, Y.-F.; Qin, C.;
Jiao, N. Chem. Commun. 2013, 49, 5654. (e) Thirunavukkarasu, V. S.;
Raghuvanshi, K.; Ackermann, L. Org. Lett. 2013, 15, 3286.
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
This work was supported by NIH (GM069559 to J.A.E.). R.G.B.
was supported by DOE (DE-AC02-05CH11231).
■
REFERENCES
■
(1) Recent reviews of Rh(III)-catalyzed C−H functionalization:
(a) Satoh, T.; Miura, M. Chem.Eur. J. 2010, 16, 11212. (b) Wencel-
Delord, J.; Droge, T.; Liu, F.; Glorius, F. Chem. Soc. Rev. 2011, 40, 4740.
(c) Song, G.; Wang, F.; Li, X. Chem. Soc. Rev. 2012, 41, 3651.
(14) (a) Recent review of acridine natural products with biological
(2) Selected reviews of heterocycle synthesis through C−H
functionalization: (a) Yamaguchi, J.; Yamaguchi, A. D.; Itami, K.
Angew. Chem., Int. Ed. 2012, 51, 8960. (b) Colby, D. A.; Bergman, R. G.;
Ellman, J. A. Chem. Rev. 2010, 110, 624. (c) Lyons, T. W.; Sanford, M. S.
Chem. Rev. 2010, 110, 1147. (d) Chen, X.; Engle, K. M.; Wang, D.-H.;
Yu, J.-Q. Angew. Chem., Int. Ed. 2009, 48, 5094. (e) Seregin, I. V.;
Gevorgyan, V. Chem. Soc. Rev. 2007, 36, 1173. (f) Ackermann, L. Acc.
Chem. Res. 2013, DOI: 10.1021/ar3002798.
́
activities: Cholewinski, G.; Dzierzbicka, K.; Kołodziejczyk, A. M.
Pharmacol. Rep. 2011, 63, 305. (b) Acrisorcinum, proflavine, and
acriflavinium chloride are examples of FDA-approved drugs that
incorporate an acridine. Selected examples using acridine derivatives
as photocatalysts or photosensitizers: (c) Hamilton, D. S.; Nicewicz, D.
A. J. Am. Chem. Soc. 2012, 134, 18577. (d) Kotani, H.; Ohkubo, K.;
Fukuzumi, S. J. Am. Chem. Soc. 2004, 126, 15999.
(15) Recent reviews of phenazine natural products with biological
activities: (a) Laursen, J. B.; Nielsen, J. Chem. Rev. 2004, 104, 1663.
(b) Pierson, L. S., III; Pierson, E. A. Appl. Microbiol. Biotechnol. 2010, 86,
1659. (c) Clofazimine and cuprimyxine are examples of FDA-approved
drugs that incorporate a phenazine.
(16) For leading references on acridine synthesis, see ref 14a.
Representative recently reported methods: (a) Tevelikhovsky, D.;
Buchwald, S. L. J. Am. Chem. Soc. 2010, 132, 14048. (b) Huang, Z.-X.;
Yang, Y.; Xiao, Q.; Zhang, Y.; Wang, J.-B. Eur. J. Org. Chem. 2012, 6586.
(c) Larock, R. C.; Rogness, D. C. J. Org. Chem. 2010, 75, 2289.
(17) For leading references on phenazine synthesis, see refs 15a and
15b. Representative recent examples of the elaboration of phenazines
and acridines using C−H functionalization: (a) Kwak, J.; Kim, M.;
Chang, S. J. Am. Chem. Soc. 2011, 133, 3780. (b) Hyodo, I.; Tobisu, M.;
Chatani, N. Chem. Commun. 2012, 48, 308.
(3) Selected recent examples of Rh(III)-catalyzed heterocycle
synthesis via coupling to alkynes: (a) Wang, H.; Grohmann, C.;
Nimphius, C.; Glorius, F. J. Am. Chem. Soc. 2012, 134, 19592.
(b) Jayakumar, J.; Parthasarathy, K.; Cheng, C.-H. Angew. Chem., Int. Ed.
2012, 51, 197. (c) Rakshit, S.; Patureau, F. W.; Glorius, F. J. Am. Chem.
Soc. 2010, 132, 9585. (d) Stuart, D. R.; Alsabeh, P.; Kuhn, M.; Fagnou,
K. J. Am. Chem. Soc. 2010, 132, 18326. (e) Xu, X.-X.; Liu, Y.; Park, C.-M.
Angew. Chem., Int. Ed. 2012, 51, 9372. (f) Wang, C.-M.; Sun, H.; Fang,
Y.; Huang, Y. Angew. Chem., Int. Ed. 2013, 52, 5795. (g) Umeda, N.;
Tsurugi, H.; Satoh, T.; Miura, M. Angew. Chem., Int. Ed. 2008, 47, 4019.
(h) Guimond, N.; Fagnou, K. J. Am. Chem. Soc. 2009, 131, 12050.
(i) Hyster, T. K.; Rovis, T. J. Am. Chem. Soc. 2010, 132, 10565. (j) Wang,
Y.-F.; Toh, K. K.; Lee, J.-Y.; Chiba, S. Angew. Chem., Int. Ed. 2011, 50,
5927. (k) Li, B.-J.; Wang, H.-Y.; Zhu, Q.-L.; Shi, Z.-J. Angew. Chem., Int.
Ed. 2012, 51, 3948. (l) Zhao, D.-B.; Wu, Q.; Huang, X.-L.; Song, F.-J.;
Lv, T.-Y.; You, J. S. Chem.Eur. J. 2013, 19, 6239. (m) Muralirajin, K.;
Cheng, C.-H. Chem.Eur. J. 2013, 19, 6198.
(18) Jun, C.-H.; Moon, C. W.; Kim, Y.-M.; Lee, H.; Lee, J. H.
Tetrahedron Lett. 2002, 43, 4233.
(19) Li, L.; Brennessel, W. W.; Jones, W. D. Organometallics 2009, 28,
3492. (b) Li, L.; Brennessel, W. W.; Jones, W. D. J. Am. Chem. Soc. 2008,
130, 12414.
(4) Recent examples of Rh(III)-catalyzed N-heterocycle synthesis via
coupling to alkenes: (a) Neely, J. M.; Rovis, T. J. Am. Chem. Soc. 2013,
135, 66. (b) Zhen, W.; Wang, F.; Zhao, M.; Du, Z.; Li, X. Angew. Chem.,
Int. Ed. 2012, 51, 11819. (c) Hyster, T. K.; Knorr, L.; Ward, T. R.; Rovis,
̈
D
dx.doi.org/10.1021/ja406131a | J. Am. Chem. Soc. XXXX, XXX, XXX−XXX